An adviser to the FDA has said that the organisation is at war with itself over its policy towards opioid drugs, accusing the organisation of failing to learn lessons from the addiction crisis ...
The opioid crisis continues to devastate the U.S. In 2021, over 107,000 people died from drug overdoses. The annual economic ...
The FDA approved the first over-the-counter drug, naloxone nasal spray, last year to help reduce drug overdose deaths.
The pharma is seeking full approval for its anticoagulation reversal drug Andexxa, which the FDA granted accelerated approval ...
The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for the emergency treatment of known or suspected opioid overdose in adults an ...
Narcan is the only reversal drug distributed free of charge to organizations in state, but it's not the only reversal drug ...
In the 1990s, overprescribing by doctors, along with aggressive and deceptive drug marketing by pharmaceutical companies, led ...
Protonitazene, a synthetic opioid three times stronger than fentanyl, was connected to an overdose in Stevenson Ranch. Dealer ...
A recent study by North Carolina State University exposes a critical shortfall in opioid treatment availability within the state's residential facilities.
AstraZeneca has ended work on an opioid use disorder (OUD) drug after the orexin 1 receptor antagonist demonstrated a ...
The FDA approved the first over-the-counter drug, naloxone nasal spray, last year to help reduce drug overdose deaths.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback